SCHOTT Pharma

Historical price data

SCHOTT Pharma's mission is to provide scientifically grounded drug containment and delivery systems that ensure the safety and efficacy of injectable medicines. The company has established itself as a market leader through its extensive portfolio of glass and polymer vials, syringes, cartridges, and ampoules, complemented by a full suite of analytical and regulatory services. Its strategy leverages deep materials science expertise to address complex challenges in biologics, mRNA, and high-potency drug formulations, positioning it as a critical enabler of modern pharmaceutical development. Following its 2023 IPO, SCHOTT Pharma is strategically expanding its high-value polymer solutions and services to capture growth in the dynamic drug delivery sector.

A dual-material platform based on proprietary Type I Borosilicate Glass formulations and high-grade pharmaceutical polymers, integrated with a full suite of analytical, regulatory, and fill-and-finish services to solve complex drug containment and delivery challenges.

SCHOTT competes with glass specialists (Gerresheimer, Nipro, Corning), polymer/device leaders (West Pharma, BD), and regional manufacturers. Its key advantages are dual-material (glass & polymer) expertise, a fully integrated product-and-service model, and a century of trusted heritage in pharmaceutical packaging.